These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? Ahmed A J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029 [TBL] [Abstract][Full Text] [Related]
31. Compliance with the safety guidelines for long-term lithium treatment in Sweden. Golic M; Aiff H; Attman PO; Ramsauer B; Schön S; Svedlund J J Psychopharmacol; 2018 Oct; 32(10):1104-1109. PubMed ID: 29896998 [TBL] [Abstract][Full Text] [Related]
32. [Neurotoxicity in elderly patients being treated with lithium: is there a reason to adjust the dosage administered?]. Bogers CH; Boshuisen ML; Kok JS; Knegtering H Tijdschr Psychiatr; 2012; 54(4):359-69. PubMed ID: 22508354 [TBL] [Abstract][Full Text] [Related]
33. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study. Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F; J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study. Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663 [TBL] [Abstract][Full Text] [Related]
36. Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial. Decloedt EH; Lesosky M; Maartens G; Joska JA AIDS Res Ther; 2017 Feb; 14(1):6. PubMed ID: 28160772 [TBL] [Abstract][Full Text] [Related]
37. [Is there an increased risk for renal tumors during long-term treatment with lithium?]. Conell J; Lewitzka U; Ritter P; Severus E; Pilhatsch M; Pfennig A; Berghöfer M; Bauer M Nervenarzt; 2015 Sep; 86(9):1157-61. PubMed ID: 26341836 [TBL] [Abstract][Full Text] [Related]
38. The prevalence of lithium-associated hyperparathyroidism in a large Swedish population attending psychiatric outpatient units. Meehan AD; Humble MB; Yazarloo P; Järhult J; Wallin G J Clin Psychopharmacol; 2015 Jun; 35(3):279-85. PubMed ID: 25853371 [TBL] [Abstract][Full Text] [Related]
39. Compliance with the guidelines for laboratory monitoring of patients treated with lithium: A retrospective follow-up study among ambulatory patients in the Netherlands. Nederlof M; Egberts TC; van Londen L; de Rotte MC; Souverein PC; Herings RM; Heerdink ER Bipolar Disord; 2019 Aug; 21(5):419-427. PubMed ID: 30472760 [TBL] [Abstract][Full Text] [Related]
40. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. Albert U; De Cori D; Aguglia A; Barbaro F; Lanfranco F; Bogetto F; Maina G J Affect Disord; 2013 Nov; 151(2):786-790. PubMed ID: 23870428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]